CXCR2 and breast cancer: Targeting the CXCL7/CXCR2 pathway with a CXCR2 antagonist (SB265610) has been reported to decrease lung metastasis prevalence and reinforce CD8(+) CTLs in the spontaneous mammary tumors of MMTV-PyMT mice in chronic circadian disruption 78.